Johnson & Johnson (NYSE: JNJ) announced today that 43 presentations showcasing the Company's rheumatology pipeline and portfolio will be featured at the American College of Rheumatology (ACR) 2024 ...
This study seeks to show that it’s possible to reverse both Rheumatoid Arthritis (RA) and Psoriasis by integrating ... Project IMPACT: Discovering the best way to manage autoimmune conditions Project ...
She is the director of the Comprehensive Arthritis and Rheumatology Center of the Caribbean and faculty at the ... This will include opportunities for learners to see the most popular content from ACR ...